Back to Results
First PageMeta Content
Pharmacology / Immune system / Immunology / Monoclonal antibodies / Fusion protein / Biologic / Polyclonal antibodies / Biosimilar / Humanized antibody / Pharmaceutical sciences / Biology / Biotechnology


Engineering Next-Generation Therapeutic Proteins: Trends and Markets toExecutive Summary Executive Summary
Add to Reading List

Document Date: 2011-08-03 14:46:23


Open Document

File Size: 658,86 KB

Share Result on Facebook

City

South San Francisco / San Francisco / /

Company

Amgen / Biogen Idec / Genentech / /

Country

United States / China / /

IndustryTerm

developers with specific tools / biotechnology / pharmaceutical protein engineering / pharmaceutical markets / biological and pharmaceutical equivalence / drug developers / venture capital providers / medium-throughput technologies / use software / on display technologies / large pharmaceutical partners / biotechnology drugs / protein engineering tools / library display technology / recombinant expression systems / pharmaceutical biotechnology / nextgeneration products / /

MarketIndex

set 60 / /

MedicalCondition

neutropenia / multiple sclerosis / diseases / anemia / /

Position

Executive / Executive Summary Executive / /

Technology

Protein engineering / genetic engineering / medium-throughput technologies / library display technology / antibodies / biotechnology / on display technologies / /

URL

www.InsightPharmaReports.com / /

SocialTag